Watch Ticker

Sutro Biopharma, Inc.

Go to Sutro Biopharma, Inc. Website

$3.40

(%)

Live

Previous Close

$3.395

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$261.1 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoim...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?

AnaptysBio (ANAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Related tickers: ANAB, STRO.

Read Full Article

Sutro Biopharma, Inc. - Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering

SOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the pricing of an underwritten offering of 14,478,764 shares of its common stock at a price of $5.18 per share. The gross proceeds from this offering are expected to be approximately $75.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by Sutro. All of the shares of common stock are being offered by Sutro. The offering is expected to close on or about April 4, 2024, subject to the satisfaction of customary closing conditions.

Related tickers: STRO.

Read Full Article

Trending Tickers

LASE

XNAS

$1.94

(%)

NYCB

XNYS

$2.65

(%)

PACW

XNAS

$7.54

(%)

XNYS

$73.00

(%)

MLGO

XNAS

$0.00

(%)